MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, AVNS had -$19,800K decrease in cash & cash equivalents over the period. $7,000K in free cash flow.

Cash Flow Overview

Change in Cash
-$19,800K
Free Cash flow
$7,000K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net (loss) income
-1,400 -70,200
Depreciation and amortization
9,400 19,600
Stock-based compensation expense
3,500 7,900
Goodwill impairment
0 77,000
Net loss on asset dispositions
-5,400 -300
Accounts receivable
-700 -22,100
Inventories
500 2,100
Prepaid expenses and other assets
3,800 -2,200
Accounts payable
1,100 -1,600
Accrued expenses
-400 -22,000
Deferred income taxes and other
0 -700
Cash provided by operating activities
14,000 32,500
Capital expenditures
7,000 17,700
Proceeds from the sale of assets
4,000 -
Proceeds from rh divestiture post-closing settlement
0 0
Acquisition of assets and investments in businesses
-28,300 -
Investments in non-affiliates
200 4,600
Cash used in investing activities
-31,500 -22,300
Secured debt repayments
2,300 4,700
Revolving credit facility proceeds
0 0
Revolving credit facility repayments
0 25,000
Purchases of treasury stock
0 3,000
Proceeds from the exercise of stock options
300 400
Payment of contingent consideration liabilities
0 0
Cash used in financing activities
-2,000 -32,300
Effect of exchange rate changes on cash and cash equivalents
-300 4,700
(decrease) increase in cash and cash equivalents
-19,800 -17,400
Cash and cash equivalents at beginning of period
107,700 -
Cash and cash equivalents at end of period
70,500 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

AVANOS MEDICAL, INC. (AVNS)

AVANOS MEDICAL, INC. (AVNS)